C. Napolitano, R. Bloise, M. Memmi, and S. G. Priori, Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT), Eur. J. Hum. Genet, vol.22, 2014.

N. Sayed, C. Liu, and J. C. Wu, Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine, J. Am. Coll. Cardiol, vol.67, pp.2161-2176, 2016.

P. Liang, K. Sallam, H. Wu, Y. Li, I. Itzhaki et al., Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome, J. Am. Coll. Cardiol, vol.68, pp.2086-2096, 2016.

W. Peng, H. Shen, J. Wu, W. Guo, X. Pan et al., Structural basis for the gating mechanism of the type 2 ryanodine receptor RyR2, Science, vol.354, 2016.

A. Moreau, A. Mercier, O. Theriault, M. Boutjdir, B. Burger et al., Molecular, and Pharmacological Characterization of Voltage-Dependent Sodium Channels from Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Can. J. Cardiol, vol.33, pp.269-278, 2017.

M. Pesl, I. Acimovic, J. Pribyl, R. Hezova, A. Vilotic et al., Forced aggregation and defined factors allow highly uniform-sized embryoid bodies and functional cardiomyocytes from human embryonic and induced pluripotent stem cells, Heart Vessels, vol.29, pp.834-846, 2014.

N. L. Thomas, C. H. George, and F. A. Lai, Role of ryanodine receptor mutations in cardiac pathology: More questions than answers?, Biochem. Soc. Trans, vol.34, pp.913-918, 2006.

C. Qu, K. A. Puttonen, H. Lindeberg, M. Ruponen, O. Hovatta et al., Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture, Int. J. Biochem. Cell Biol, vol.45, pp.1802-1812, 2013.

A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D. D. Ngoc et al., Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients, Circulation, vol.91, pp.1512-1519, 1995.

M. Pesl, J. Pribyl, I. Acimovic, A. Vilotic, S. Jelinkova et al., Atomic force microscopy combined with human pluripotent stem cell derived cardiomyocytes for biomechanical sensing, Biosens. Bioelectr, vol.85, pp.751-757, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01800823

N. Sun, M. Yazawa, J. Liu, L. Han, V. Sanchez-freire et al., Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy, Sci. Transl. Med, 2012.

J. Liu, N. Sun, M. A. Bruce, J. C. Wu, and M. J. Butte, Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes, PLoS ONE, vol.7, p.37559, 2012.

D. Pasquale, E. Lodola, F. Miragoli, M. Denegri, M. Avelino-cruz et al., CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia, Cell Death Dis, 2013.

A. M. Bellinger, S. Reiken, M. Dura, P. W. Murphy, S. X. Deng et al., Remodeling of ryanodine receptor complex causes "leaky" channels: A molecular mechanism for decreased exercise capacity, Proc. Natl. Acad. Sci, vol.105, pp.2198-2202, 2008.

J. Shan, W. Xie, M. Betzenhauser, S. Reiken, B. X. Chen et al., Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia, Circ. Res, vol.111, pp.708-717, 2012.

J. Fauconnier, A. C. Meli, J. Thireau, S. Roberge, J. Shan et al., Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion, Proc. Natl. Acad. Sci, vol.108, pp.13258-13263, 2011.

X. H. Wehrens, S. E. Lehnart, F. Huang, J. A. Vest, S. R. Reiken et al., 6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death, Cell, vol.113, pp.829-840, 2003.

M. Fernandez-velasco, A. Rueda, N. Rizzi, J. P. Benitah, B. Colombi et al., Increased Ca 2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia, Circ. Res, vol.104, pp.201-209, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00422019

A. C. Meli, M. M. Refaat, M. Dura, S. Reiken, A. Wronska et al., A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium, Circ. Res, vol.109, pp.281-290, 2011.

J. Shan, M. J. Betzenhauser, A. Kushnir, S. Reiken, A. C. Meli et al., Role of chronic ryanodine receptor phosphorylation in heart failure and beta-adrenergic receptor blockade in mice, J. Clin. Investig, vol.120, pp.4375-4387, 2010.

A. Novak, L. Barad, N. Zeevi-levin, R. Shick, R. Shtrichman et al., Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to beta-adrenergic stimulation, J. Cell. Mol. Med, vol.16, pp.468-482, 2012.

I. Itzhaki, L. Maizels, I. Huber, A. Gepstein, G. Arbel et al., Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells, J. Am. Coll. Cardiol, vol.60, pp.990-1000, 2012.

K. Sasaki, T. Makiyama, Y. Yoshida, Y. Wuriyanghai, T. Kamakura et al., Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia, PLoS ONE, vol.11, 2016.

M. K. Preininger, R. Jha, J. T. Maxwell, Q. Wu, M. Singh et al., A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses, Dis. Models Mech, vol.9, pp.927-939, 2016.

R. Zalk, O. B. Clarke, A. Georges, R. A. Grassucci, S. Reiken et al., Structure of a mammalian ryanodine receptor, Nature, vol.517, pp.44-49, 2015.

S. O. Marx, S. Reiken, Y. Hisamatsu, M. Gaburjakova, J. Gaburjakova et al., Phosphorylation-dependent regulation of ryanodine receptors: A novel role for leucine/isoleucine zippers, J. Cell Biol, vol.153, pp.699-708, 2001.

C. B. Jung, A. Moretti, M. Mederos-y-schnitzler, L. Iop, U. Storch et al., Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia, EMBO Mol. Med, vol.4, pp.180-191, 2012.

P. Neco, A. G. Torrente, P. Mesirca, E. Zorio, N. Liu et al., Paradoxical effect of increased diastolic Ca( 2+ ) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia, Circulation, vol.126, pp.392-401, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02477214

A. Lymperopoulos, K. A. Mccrink, and A. Brill, Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol, Curr. Drug Metab, vol.17, pp.30-36, 2015.

J. W. Cheung, A. C. Meli, W. Xie, S. Mittal, S. Reiken et al., Short-coupled polymorphic ventricular tachycardia at rest linked to a novel ryanodine receptor (RyR2) mutation: Leaky RyR2 channels under non-stress conditions, Int. J. Cardiol, vol.180, pp.228-236, 2015.

J. Fauconnier, J. Thireau, S. Reiken, C. Cassan, S. Richard et al., Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy, Proc. Natl. Acad. Sci, vol.107, pp.1559-1564, 2010.

S. E. Lehnart, M. Mongillo, A. Bellinger, N. Lindegger, B. X. Chen et al., Leaky Ca 2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice, J. Clin. Investig, vol.118, pp.2230-2245, 2008.

S. E. Lehnart, X. H. Wehrens, P. J. Laitinen, S. R. Reiken, S. X. Deng et al., Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak, Circulation, vol.109, pp.3208-3214, 2004.

X. Liu, M. J. Betzenhauser, S. Reiken, A. C. Meli, W. Xie et al., Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction, Cell, vol.150, pp.1055-1067, 2012.

J. Shan, A. Kushnir, M. J. Betzenhauser, S. Reiken, J. Li et al., Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice, J. Clin. Investig, vol.120, pp.4388-4398, 2010.

F. Syeda, A. P. Holmes, T. Y. Yu, S. Tull, S. M. Kuhlmann et al., PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers, J. Am. Coll. Cardiol, vol.25, pp.1881-1894, 2016.

C. Van-der-werf, P. J. Kannankeril, F. Sacher, A. D. Krahn, S. Viskin et al., Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia, J. Am. Coll. Cardiol, vol.57, pp.2244-2254, 2011.

M. L. Bannister, N. L. Thomas, M. B. Sikkel, S. Mukherjee, C. Maxwell et al., The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2, Circ. Res, vol.116, pp.1324-1335, 2015.